Patients' Preferences for Treatment for Dupuytren's Disease: A Discrete Choice Experiment

被引:28
|
作者
Kan, Hester J. [1 ]
de Bekker-Grob, Esther W.
van Marion, Eva S.
van Oijen, Guido W.
van Nieuwenhoven, Christianne A.
Zhou, Chao
Hovius, Steven E. R.
Selles, Ruud W.
机构
[1] Erasmus Univ, Med Ctr, Dept Plast & Reconstruct Surg & Hand Surg, NL-3000 CA Rotterdam, Netherlands
关键词
PERCUTANEOUS NEEDLE FASCIOTOMY; COLLAGENASE CLOSTRIDIUM-HISTOLYTICUM; LIMITED FASCIECTOMY; FOLLOW-UP; CONTRACTURE; OUTCOMES; TRIAL;
D O I
10.1097/PRS.0000000000001878
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Although in modern medicine, patients' preferences are important, these have never been defined for characteristics of Dupuytren treatment. This study determines these patients' preferences using a discrete choice experiment. Methods: A multicenter discrete choice experiment study was conducted among patients with Dupuytren's disease who had been treated previously. Patients were asked about their preferences for attributes of Dupuytren treatments using scenarios based on treatment method, major and minor complication rates, recurrence rates, convalescence, residual extension deficit after treatment, and aesthetic results. The relative importance of these attributes and the tradeoffs patients were willing to make between them were analyzed using a panel latent class logit model. Results: Five-hundred six patients completed the questionnaire. All above-mentioned attributes proved to influence patients' preferences for Dupuytren treatment (p < 0.05). Preference heterogeneity was substantial. Men who stated they performed heavy labor made different tradeoffs than women or men who did not perform heavy labor. In general, recurrence rate (36 percent) and extension deficit (28 percent) were the most important attributes in making treatment choices, followed by minor complication rate (13 percent). Patients accepted an increase in recurrent disease of 11 percent if they could receive needle aponeurotomy treatment instead of limited fasciectomy. Conclusions: This study confirms the importance of low recurrence rates and complete contracture corrections, but also emphasizes the significance of low complication rates. Convalescence was not an attribute, which scored high. The preference heterogeneity shows that patient consultations need to be targeted differently, which may result in different treatment decisions, depending on patient characteristics and preferences.
引用
收藏
页码:165 / 173
页数:9
相关论文
共 50 条
  • [1] Patients' Preferences for Scoliosis Brace Treatment A Discrete Choice Experiment
    Bunge, Eveline M.
    de Bekker-Grob, Esther W.
    van Biezen, Frans C.
    Essink-Bot, Marie-Louise
    de Koning, Harry J.
    [J]. SPINE, 2010, 35 (01) : 57 - 63
  • [2] PATIENTS' PREFERENCES FOR OSTEOPOROSIS DRUG TREATMENT: A DISCRETE CHOICE EXPERIMENT
    Hiligsmann, M.
    Dellaert, B.
    Dirksen, C.
    van der Weijden, T.
    Goemaere, S.
    Reginster, J. -Y.
    Watson, V.
    Boonen, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 978 - 978
  • [3] Patients’ preferences for osteoporosis drug treatment: a discrete choice experiment
    E. W. de Bekker-Grob
    M. L. Essink-Bot
    W. J. Meerding
    H. A. P. Pols
    B. W. Koes
    E. W. Steyerberg
    [J]. Osteoporosis International, 2008, 19 : 1029 - 1037
  • [4] Patients' preferences for osteoporosis drug treatment: a discrete choice experiment
    de Bekker-Grob, E. W.
    Essink-Bot, M. L.
    Meerding, W. J.
    Pols, H. A. P.
    Koes, B. W.
    Steyerberg, E. W.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2008, 19 (07) : 1029 - 1037
  • [5] Professionals' Treatment Preferences in the Prodromal Phase of Parkinson's Disease: A Discrete Choice Experiment
    van den Heuvel, Lieneke
    Hoefsloot, Wibe
    Post, Bart
    Meinders, Marjan J.
    Bloem, Bastiaan R.
    Stiggelbout, Anne M.
    van Til, Janine A.
    [J]. JOURNAL OF PARKINSONS DISEASE, 2022, 12 (05) : 1655 - 1664
  • [6] TREATMENT PREFERENCES IN FABRY DISEASE: A DISCRETE CHOICE EXPERIMENT IN DENMARK AND THE UK
    Gallop, K.
    Lloyd, A.
    MacCulloch, A.
    Nordin, S.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S213 - S213
  • [7] Treatment preferences in Fabry disease, a discrete choice experiment in the UK and Denmark
    MacCulloch, Alasdair C.
    Lloyd, Andrew
    Gallop, Katy
    Nordin, Sofia
    [J]. MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S79 - S79
  • [8] Preferences for exercise in people with Parkinson's disease: A discrete choice experiment
    Paul, S.
    Canning, C.
    Lofgren, N.
    Sherrington, C.
    Lee, D.
    Bampton, J.
    Howard, K.
    [J]. MOVEMENT DISORDERS, 2020, 35 : S552 - S552
  • [9] Patient's preferences for osteoporosis drug treatment: A discrete choice experiment
    De, Bekker-Grob E. W.
    Essink-Bot, M. L.
    Meerding, W. J.
    Pols, H. A. P.
    Koes, B. W.
    Steyerberg, E. W.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A229 - A229
  • [10] Patients’ preferences for osteoporosis drug treatment: a discrete-choice experiment
    Mickaël Hiligsmann
    Benedict G Dellaert
    Carmen D Dirksen
    Trudy van der Weijden
    Stefan Goemaere
    Jean-Yves Reginster
    Verity Watson
    Annelies Boonen
    [J]. Arthritis Research & Therapy, 16